Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Cancer, Molecular Diagnostics |
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by Laurie Bonner | Jul 24, 2020 | Company News |
The 2020 ServiceTrak Clinical Laboratory Awards are based on interviews with respondents in 2,229 clinical testing locations having 5,117 instruments.
Read MorePosted by Laurie Bonner | Jul 9, 2020 | Accreditation |
Updates include new criteria in the areas of immunohematology, transfusion services, and mass spectrometry.
Read MorePosted by Laurie Bonner | Jul 3, 2020 | Company News, Hematology & Serology |
This new laboratory diagnostic products contract will offer Vizient members a full range of hematology analyzers, reagents, and services.
Read MorePosted by Laurie Bonner | Jun 30, 2020 | Hematology & Serology |
iCoagLab is a novel, inexpensive, and portable device that can quickly and accurately measure the ability of blood to properly clot.
Read More